Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial

Benjamin Lee, Nathan Mynard, Abu Nasar, Jonathan Villena-Vargas, Oliver Chow, Sebron Harrison, Brendon Stiles, Jeffrey Port, Nasser Altorki

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences